Valuation : Stemcell United Limited

Market Cap 3.53M 2.54M 2.19M 2.05M 1.88M 3.5M 240M 24.26M 9.45M 123M 9.54M 9.33M 395M P/E 2024
-0.35x
P/E 2025 -0.75x
Enterprise Value 3.38M 2.43M 2.09M 1.96M 1.8M 3.35M 230M 23.21M 9.04M 117M 9.13M 8.93M 378M EV / Sales 2024
11.9x
EV / Sales 2025 5.53x
Free-Float
89.66%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 55 2023-11-20
Chief Tech/Sci/R&D Officer - 2026-05-24
Corporate Secretary - 2024-04-10
Director TitleAgeSince
Chairman - 2026-06-21
Director/Board Member 55 2023-03-29
Director/Board Member - 2019-05-26
Change 5-day change 1-year change 3-year change Capi.($)
+50.00%-.--% - - 1.69M
-0.24%-1.09%+2.00%+17.50% 50.14B
+0.53%-4.81%+429.34%+524.87% 44.85B
+1.53%+2.23%+45.28%+21.43% 43.43B
-0.03%-2.78%+7.70%+76.79% 41.14B
+0.43%-3.26%+14.75%+49.08% 32.92B
+0.67%+8.63% - - 17.56B
-1.02%-3.90%+22.13%+121.70% 16.55B
+0.93%+0.63%+16.86%+29.29% 14.65B
-0.84%-2.30%+78.41%+41.76% 13.93B
Average +5.19%-0.77%+77.06%+110.30% 30.57B
Weighted average by Cap. +0.29%-1.13%+92.50%+128.68%

Financials

2024 2025
Net sales 110K 79.13K 68.08K 63.89K 58.45K 109K 7.48M 756K 294K 3.82M 297K 291K 12.31M 352K 254K 218K 205K 187K 350K 23.97M 2.42M 943K 12.25M 952K 931K 39.45M
Net income -2.65M -1.91M -1.64M -1.54M -1.41M -2.63M -180M -18.23M -7.1M -92.18M -7.17M -7.01M -297M -1.49M -1.07M -920K -864K -790K -1.47M -101M -10.22M -3.98M -51.68M -4.02M -3.93M -166M
Net Debt 119K 85.99K 73.98K 69.43K 63.52K 119K 8.13M 821K 320K 4.15M 323K 316K 13.38M -153K -110K -94.57K -88.74K -81.19K -152K -10.39M -1.05M -409K -5.31M -413K -404K -17.1M
Logo Stemcell United Limited
BPH Global Limited is an Australia-based plant-focused biotechnology company. The Company is focused on producing foods, health and cosmetic products which deliver Traditional Chinese Medicine (TCM)-based health outcomes. It focuses on the research and development, production and commercialization of TCM products, including raw bird’s nest and processed bird’s nest products, raw seaweed and sea plants as sustainable plant-based protein foods and nutraceutical and pharmaceutical ingredients extracted from seaweed and sea plants for utilization in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. The Company’s product focus is on raw bird’s nests; higher end processed bird’s nest products; and Sea Grapes (Caulerpa Lentillifera) and seaweeds. Its subsidiaries include Hainan SCU Biotechnology Co Ltd, Foshan Gedishi Biotechnology Co Ltd, SCU Lab Pty Ltd, PT BPH Global Indonesia, Stemcell United Pte Ltd and others.
Employees
-